SCHEMBL25677435

SCHEMBL25677435

CC(C)(C)c1cc(C(C)(C)C)c2c(c1)c1ccccc1n2-c1nc(-c2ccc(-c3ccccc3)cc2)nc(-n2c3ccccc3c3ccccc32)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 2/20 0.38
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ TP53 P04637 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ GBA1 P04062 1/20 0.34
▸ NPSR1 Q6W5P4 3/20 0.32
▸ MAPT P10636 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ MAP3K5 Q99683 1/20 0.32
▸ TSPO P30536 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ USP2 O75604 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ NPC1 O15118 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ RXRA P19793 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25677406 0.96 ABCG2 (0.40) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677429 0.94 ABCG2 (0.35) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677403 0.94 ABCG2 (0.40) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677433 0.93 ABCG2 (0.35) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677427 0.91 KDM4E (0.38) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677422 0.91 KIF11 (0.32) LMNAKDM4E
SCHEMBL25677425 0.91 KIF11 (0.32) LMNAKDM4E
SCHEMBL25677415 0.90 MEN1 (0.35) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677438 0.90 ABCG2 (0.33) ABCG2MEN1KMT2ARAB9A
SCHEMBL25677449 0.89 KIF11 (0.33) NPSR1MAPTALDH1A1MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172064-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-01 — — US disclosed
US-20230172064-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172064-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, NQO1, CYP2E1 ABCG2 3616/4885MEN1 212/4885KMT2A 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback